Case Control Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Aug 27, 2023; 15(8): 1629-1640
Published online Aug 27, 2023. doi: 10.4240/wjgs.v15.i8.1629
Table 1 Characteristics of patients undergoing endoscopic submucosal dissection and laparoscopic surgery

ESD with/without backup surgery (n = 100)
Laparoscopic surgery (n = 94)
OR (95%CI)
P value
Age, yr, median (range) 56 (49-62)62 (52-70)1.04 (1.02-1.07)0.001a
Male gender, n (%)46 (46)47 (50)1.17 (0.67-2.06)0.577
Tumor size, n (%)
    ≤ 2 cm72 (72)15 (16)1
    3-5 cm26 (26)54 (57.4)9.97 (4.82-20.62)< 0.001a
    > 5 cm2 (2)25 (26.6)60 (12.81-281)< 0.001a
Tumor location, n (%)
    Upper81 (81)61 (64.9)1
    Middle6 (6)14 (14.9)3.1 (1.13-8.53)0.029a
    Low13 (13)19 (20.2)1.94 (0.89-4.23)0.096
Layer of tumor origin, n (%)
    Submucosa6 (6)3 (3.2)1
    Muscularis propria94 (94)91 (96.8)1.94 (0.47-7.97)0.36
Exophytic growth, n (%)11 (11)53 (56.4)10.46 (4.95-22.08)< 0.001a
Pathology, n (%)
    Benign55 (55)14 (14.9)1
    Malignant or malignant potential45 (45)80 (85.1)6.98 (3.5-13.94)< 0.001a
Procedure time, min, median (IQR)75 (40-138)130 (100-169)-< 0.001a
Length of stay, d, median (IQR)5 (4-7)6 (4-6)-0.923
Clavien ≥ III complication, n (%)5 (5)3 (3.2)-0.527
Table 2 Characteristics of endoscopic submucosal dissection with backup surgery and laparoscopic surgery

ESD with backup surgery (n = 27)
Laparoscopic surgery (n = 94)
OR (95%CI)
P value
Age, yr, median (range) 56 (50-64)62 (52-70)1.03 (1.00-1.06)0.053
Male gender, n (%)9 (33.3)47 (50)2.00 (0.82-4.90)0.13
Tumor size, n (%)
    ≤ 2 cm16 (59.3)15 (16)1
    3-5 cm11 (40.7)54 (57.4)7.66 (2.98-19.72)< 0.001a
    > 5 cm0 (0)25 (26.6)
Tumor location, n (%)
    Upper23 (85.2)61 (64.9)1
    Middle1 (3.7)14 (14.9)3.11 (0.99-9.76)0.052
    Low3 (11.1)19 (3.2)
Layer of tumor origin, n (%)
    Submucosa0 (0)3 (3.2)-1
    Muscularis propria27 (100)91 (96.8)-
Exophytic growth, n (%)10 (37)53 (56.4)2.20 (0.91-5.3)0.08
Pathology, n (%)
    Benign11 (40.7)14 (14.9)1
    Malignant or malignant potential16 (59.3)80 (85.1)3.93 (1.51-10.21)0.005a
Procedure time, min, median (IQR)185 (150-245)130 (100-169)-< 0.001a
Length of stay, d, median (IQR)7 (7-8)6 (4-6)-< 0.001a
Clavien ≥ III complication, n (%)0 (0)3 (3.2)-0.347
Table 3 Factors affecting procedure time and length of stay in endoscopic submucosal dissection with backup surgery and laparoscopic surgery
Factors
Without matched data
Propensity score matching
Adjusted mean difference
SE
P value
Adjusted mean difference
SE
P value
Procedure time
    Surgery type
            ESD with backup surgeryReferenceReference
            Laparoscopic surgery-63.42 14.70 < 0.001a-56.40 18.60 0.005a
    Age-0.43 0.42 0.304 ---
    Tumor size 222.04 13.35 0.101 ---
    Tumor location: middle or low33.58 12.54 0.008a---
    Exophytic growth-4.54 10.98 0.680 ---
    Pathology with malignancy-13.81 15.59 0.378 ---
Length of stay
    Surgery type
            ESD with backup surgery
            Laparoscopic surgery-1.2151.0890.267-2.000.5160.001a
    Age0.0810.031a0.009a---
    Tumor size 2-0.3480.9880.726---
    Tumor location: middle or low0.4570.9280.624---
    Exophytic growth-0.2180.8130.789---
    Pathology with malignancy-0.2681.1540.817---
Table 4 Malignant pathology and clinical outcomes after endoscopic submucosal dissection and laparoscopic surgery

ESD with/without backup surgery (n = 100)
Laparoscopic surgery (n = 94)
P value
Malignant pathology in the group, n (%)45 (45)80 (85.1)< 0.001a
Malignant pathology
GIST, n (%)43 (43)78 (83.1)< 0.001a
High risk0 (0)11 (14.1)0.001a
Intermediate risk5 (11.6)20 (25.6)0.002a
Low risk12 (27.9)36 (46.2)< 0.001a
Very low risk26 (60.5)11 (14.1)0.019a
Neuroendocrine tumor, n (%)1 (1)1 (1)1.000
Lipoleiomyosarcoma, n (%)01 (1)0.485
Recurrence, n (%)06 (6.4)0.012a
Disease related mortality, n (%)02 (2.1)0.233